Skip to main content

RENAL CANCER

Tracking # 20-829425

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

RENAL CELL CARCINOMA (RCC) IS THE MOST COMMON MALIGNANT TUMOR OF THE KIDNEY AND CONSTITUTES OVER 90 PERCENT OF ALL RENAL MALIGNANCIES. RCC MAY BE SPORADIC (~96%) OR FAMILIAL (4%) AND IS A HETEROGENEOUS GROUP OF DISORDERS THAT ARE SUB-CLASSIFIED INTO SEVERAL DISTINCT SUB-TYPES ASSOCIATED WITH DISTINCT GENETIC ABNORMALITIES. THIS ACTIVITY REVIEWS THE EVALUATION AND MANAGEMENT OF RENAL CELL CARCINOMA AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN IMPROVING CARE FOR PATIENTS OF RENAL CELL CARCINOMA.

Subject areas

This course counts toward the state boards and subject areas below.

Florida Board of Osteopathic Medicine

Osteopathic Physician

1h General